Question to the Department of Health and Social Care:

To ask Her Majesty’s Government, in the light of the result of the referendum on the UK's membership of the EU, what plans they have for ensuring that the conditional approval of the European Medicines Agency for new treatments continues to have validity in the UK.

The previous Prime Minister was clear that the negotiation for Britain's future relationship with Europe needed to begin under the new Prime Minister, and we now have got to look at all the detailed arrangements.

The Department has launched a ministerial industry strategy group to prepare for the renegotiation on the new European Union/United Kingdom relationship, which includes looking at the relationship between the UK and the EU medicines regulatory framework.